{"pmid":32232551,"title":"COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence.","text":["COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence.","Rheumatol Int","Venerito, Vincenzo","Lopalco, Giuseppe","Iannone, Florenzo","32232551"],"journal":"Rheumatol Int","authors":["Venerito, Vincenzo","Lopalco, Giuseppe","Iannone, Florenzo"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32232551","week":"202014|Mar 30 - Apr 05","doi":"10.1007/s00296-020-04566-9","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662899337742516224,"score":7.3910046,"similar":[{"pmid":32232552,"title":"Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.","text":["Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.","Rheumatol Int","Georgiev, Tsvetoslav","32232552"],"journal":"Rheumatol Int","authors":["Georgiev, Tsvetoslav"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32232552","week":"202014|Mar 30 - Apr 05","doi":"10.1007/s00296-020-04570-z","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1662899337639755776,"score":69.16366},{"pmid":32205336,"title":"Are my patients with rheumatic diseases at higher risk of COVID-19?","text":["Are my patients with rheumatic diseases at higher risk of COVID-19?","Ann Rheum Dis","Figueroa-Parra, Gabriel","Aguirre-Garcia, Gloria Mayela","Gamboa-Alonso, Carmen Magdalena","Camacho-Ortiz, Adrian","Galarza-Delgado, Dionicio Angel","32205336"],"journal":"Ann Rheum Dis","authors":["Figueroa-Parra, Gabriel","Aguirre-Garcia, Gloria Mayela","Gamboa-Alonso, Carmen Magdalena","Camacho-Ortiz, Adrian","Galarza-Delgado, Dionicio Angel"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32205336","week":"202013|Mar 23 - Mar 29","doi":"10.1136/annrheumdis-2020-217322","keywords":["DMARDs (biologic)","DMARDs (synthetic)","autoimmune diseases","epidemiology","infections"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662334543406825472,"score":42.464718}]}